HK:2496 Stock Latest News
Company AnnouncementsWuhan YZY Biopharma Seeks Shareholder Nod for Insider Share Subscription and Whitewash Waiver2d ago2496
Company AnnouncementsWuhan YZY Biopharma Sets November EGM to Approve Capital and Governance Changes4d ago2496
Company AnnouncementsYZY Biopharma Doses First Patient in Phase I Trial of Emicizumab Biosimilar Y2252w ago2496
Company AnnouncementsWuhan YZY Biopharma Seeks Extension for Key Share Subscription Circular1M ago2496
Company AnnouncementsWuhan YZY Biopharma Reshapes Company Secretary and Process Agent Roles1M ago2496
Company AnnouncementsWuhan YZY Biopharma Plans Major Connected Share Issue Requiring Whitewash Waiver1M ago2496Company AnnouncementsWuhan YZY Biopharma Halts Hong Kong Trading Ahead of Takeover-Related Announcement2M ago2496
Company AnnouncementsWuhan YZY Biopharma Sets Board Meeting to Approve Interim 2026 Results2M ago2496
Company AnnouncementsWuhan YZY Biopharma AGM Approves 2025 Results, Profit Plan and Auditor Reappointment4M ago2496
Company AnnouncementsWuhan YZY Biopharma Sets 2026 AGM to Approve 2025 Results and Share Issuance Mandate4M ago2496- Company AnnouncementsYZY Biopharma’s M701 Shows Promising Phase III Data Ahead of 2026 ASCO5M ago2496
Company AnnouncementsWuhan YZY Biopharma Reshapes Supervisory Committee With New Employee Representative5M ago2496Company AnnouncementsYZY Biopharma’s M701 Data Secured for High-Profile ASCO 2026 Presentations6M ago2496
Company AnnouncementsWuhan YZY Biopharma Completes Full Circulation of H Shares to Boost Market Liquidity7M ago2496- Company AnnouncementsWuhan YZY Biopharma Swings to Net Liabilities as 2025 Revenue Falls7M ago2496
Company AnnouncementsWuhan YZY Biopharma Sets March Board Meeting to Approve 2025 Final Results7M ago2496- Company AnnouncementsWuhan YZY Biopharma Confirms Land and Building Transfer Will Not Affect R&D or Commercial Plans8M ago2496
Company AnnouncementsWuhan YZY Biopharma Wins HKEX Approval for Full H-Share Circulation of 35% Stake9M ago2496Company AnnouncementsWuhan YZY Biopharma Wins FDA IND Approval for Bispecific Antibody M701 in Malignant Pleural Effusion9M ago2496
Company AnnouncementsWuhan YZY Biopharma Clears CSRC Filing for H Share Full Circulation Plan9M ago2496
